DVLA £1,000 driving fine risk over 209 medical conditions
The DVLA tells motorists there are multiple conditions they may need to declare to avoid the risk of breaking the rules
UK drivers are being cautioned that they must inform officials about medical conditions that could affect their driving. The DVLA (Driver and Vehicle Licensing Agency) warns that failure to disclose one of 209 conditions could result in a fine of up to £1,000.
The DVLA suggests that if you have one of the listed conditions, you might even consider voluntarily surrendering your licence. This might be an option for those who have been advised by their doctor to refrain from driving for three months or more.
You might also consider this if your medical condition compromises your ability to drive safely for a period of three months or longer. Or you might need to do this if your medical condition means you do not meet the necessary standards for driving.
If you decide to take this step, the DVLA says: "You'll need to tell DVLA and send them your licence. If you have a medical condition that affects your driving and do not voluntarily give up your licence, you must inform DVLA. They will decide if you can continue holding a driving licence."
Medical conditions you may need to declare to the DVLA - full list
The list of 209 conditions here applies to those with a car. If you have a bus, lorry or coach licence, "you cannot use the online service to check for your condition or report it to DVLA", they add.
Check the guidance on seizures and epilepsy Check the guidance on acoustic neuroma Check the guidance on Addison's disease Check the guidance on agoraphobia Check the guidance on alcohol problems Check the guidance on Alzheimers disease Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on amputations Check the guidance on motor neuron disease - also known as ALS Check the guidance on angina Check the guidance on heart attacks and angioplasty Check the guidance on ankylosing spondylitis Check the guidance on eating disorders
Check the guidance on anxiety Check the guidance on aortic aneurysms Check the guidance on arachnoid cysts
Check the guidance on arrhythmias Check the guidance on defibrillators Check the guidance on arteriovenous malformations
Check the guidance on arthritis Check the guidance on autistic spectrum condition, including asperger syndrome Check the guidance on ataxia, including Friedrich's ataxia
Check the guidance on ADHD Check the guidance on autistic spectrum condition, including asperger syndrome
B
Check the guidance on balloon angioplasties in the leg
Check the guidance on bipolar disorder - previously known as manic depression Check the guidance on blackouts and fainting Check the guidance on eye conditions
Check the guidance on blood clots Check the guidance on blood pressure Check the guidance on brachial plexus injuries
Check the guidance on brain abscesses, cysts or encephalitis Check the guidance on brain aneurysms Check the guidance on angiomas
Check the guidance on brain haemorrhages Check the guidance on traumatic brain injuries Check the guidance on brain tumours
Check the guidance on broken limbs Check the guidance on Brugada syndrome Check the guidance on burr hole surgery
C
Check the guidance on surgery Check the guidance on cancer (not including leukaemia) Check the guidance on eye conditions
Check the guidance on catheter ablations Check the guidance on cardiac problems Check the guidance on carotid artery stenosis
Check the guidance on cataplexy Check the guidance on cavernomas Check the guidance on central venous thrombosis
Check the guidance on cerebral palsy Check the guidance on Charcot-Marie-Tooth disease Check the guidance on Chiari malformation
Check the guidance on chronic aortic dissection Check the guidance on cognitive problems Check the guidance on congenital heart disease
Check the guidance on fits, convulsions and seizures Check the guidance on coronary artery bypass or disease Check the guidance on heart attacks and angioplasty
Check the guidance on eye conditions Check the guidance on cystic fibrosis
D
Check the guidance on deafness Check the guidance on defibrillators Check the guidance on deja vu
Check the guidance on dementia Check the guidance on depression Check the guidance on diabetes
Check the guidance on dilated cardiomyopathy Check the guidance on eye conditions Check the guidance on dizziness (including vertigo)
Check the guidance on drug misuse
E
Check the guidance on eating disorders Check the guidance on brain empyemas
Check the guidance on seizures and epilepsy Check the guidance on essential tremors Check the guidance on eye conditions
F
Check the guidance on blackouts and fainting Check the guidance on fits, convulsions and seizures Check the guidance on head injuries
Check the guidance on ataxia, including Friedrich's ataxia
G
Check the guidance on eye conditions Check the guidance on global amnesia
Check the guidance on seizures and epilepsy Check the guidance on Guillain Barré syndrome
H
Check the guidance on head injuries
Check the guidance on heart attacks and angioplasty Check the guidance on arrhythmias Check the guidance on heart failure
Check the guidance on heart murmurs Check the guidance on heart palpitations
Check the guidance on high blood pressure Check the guidance on HIV Check the guidance on Hodgkin's lymphoma
Check the guidance on Huntington's disease Check the guidance on hydrocephalus Check the guidance on high blood pressure
Check the guidance on hypertrophic cardiomyopathy Check the guidance on hypoglycaemia Check the guidance on hypoxic brain damage
Check the guidance on surgery
I
Check the guidance on defibrillators Check the guidance on intracerebral haemorrhages
Check the guidance on ischaemic heart disease
K
Check the guidance on kidney dialysis (also known as renal dialysis Check the guidance on kidney problems
Check the guidance on Korsakoff's syndrome
L
Check the guidance on labyrinthitis Check the guidance on learning difficulties
Check the guidance on left bundle branch blocks Check the guidance on leukaemia Check the guidance on Lewy body dementia
Check the guidance on limb disability Check the guidance on Long QT syndrome Check the guidance on monocular vision
Check the guidance on hypoglycaemia Check the guidance on lumboperitoneal shunts Check the guidance on lung cancer
Check the guidance on lymphoma
M
Check the guidance on eye conditions Check the guidance on brain tumours
Check the guidance on malignant melanoma Check the guidance on bipolar disorder - previously known as manic depression Check the guidance on Marfan's syndrome
Check the guidance on medulloblastomas Check the guidance on severe memory problems Check the guidance on meningioma
Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on monocular vision Check the guidance on motor neurone disease
Check the guidance on multiple sclerosis Check the guidance on muscular dystrophy Check the guidance on myasthenia gravis
Check the guidance on heart attacks and angioplasty Check the guidance on myoclonus
N
Check the guidance on narcolepsy
Check the guidance on eye conditions Check the guidance on excessive sleepiness
Check the guidance on eye conditions
P
Check the guidance on pacemakers
Check the guidance on heart palpitations Check the guidance on paranoia Check the guidance on paranoia
Check the guidance on paraplegia Check the guidance on Parkinson's disease Check the guidance on peripheral arterial disease
Check the guidance on peripheral neuropathy Check the guidance on personality disorders Check the guidance on seizures and epilepsy
Check the guidance on pituitary tumours Check the guidance on PTSD Check the guidance on psychosis
Check the guidance on psychotic depression Check the guidance on pulmonary arterial hypertension
R
Check the guidance on kidney dialysis (also known as renal dialysis
Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on eye conditions Check the guidance on eye conditions
S
Check the guidance on schizo-affective disorders Check the guidance on schizophrenia Check the guidance on scotoma
Check the guidance on fits, convulsions and seizures Check the guidance on severe communication disorders Check the guidance on severe depression
Check the guidance on monocular vision Check the guidance on excessive sleepiness Check the guidance on excessive sleepiness
Check the guidance on spinal problems Check the guidance on strokes Check the guidance on subarachnoid haemorrhages
Check the guidance on surgery Check the guidance on blackouts and fainting
T
Check the guidance on tachycardia
Check the guidance on seizures and epilepsy Check the guidance on seizures and epilepsy Check the guidance on Tourette's syndrome
Check the guidance on global amnesia Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on eye conditions
U
V
Check the guidance on heart valve disease or replacement valves Check the guidance on defibrillators
Check the guidance on dizziness (including vertigo) Check the guidance on monocular vision Check the guidance on eye conditions Check the guidance on eye conditions
W
Wolff-Parkinson-White syndrome
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
21 hours ago
- Medical News Today
Insulin resistance test may help predict early Alzheimer's cognitive decline rate
There is currently no tool for predicting how quickly early stage Alzheimer's disease will progress. A new study has identified a simple blood test used to measure insulin resistance that may also help doctors determine which people with early stage Alzheimer's disease are most likely to experience rapid cognitive decline. The test found that higher insulin resistance indicated quicker deterioration in cognitive estimate that about 69 million people around the world are living with prodromal Alzheimer's disease, or early stage Alzheimer's disease. People in the earliest stage of Alzheimer's disease begin to experience some mild cognitive impairment that may affect their memory and ability to complete tasks and communicate. Past studies show that detecting Alzheimer's disease in its earliest stage allows currently available medications and lifestyle changes to be more effective in helping to slow down disease progression. 'Alzheimer's (disease) begins silently, often decades before symptoms appear, and so detecting risk early is essential to slow or alter the disease course,' Bianca Gumina, MD, a neurology resident for the Neurology Unit in the Department of Clinical and Experimental Sciences at the University of Brescia and for the Neurology Unit in the Department of Continuity of Care and Frailty at ASST Spedali Civili Hospital, both in Italy, told Medical News Today. 'Current tools can diagnose the disease, but they don't always predict how fast it will progress. Identifying individuals at higher risk of rapid decline [c]ould allow for timely, targeted interventions during a critical window when the disease could be still responsive to treatment or changes in (lifestyle),' she is part of the research team for a study recently presented at the European Academy of Neurology (EAN) Congress 2025 that has identified a simple blood test used to measure insulin resistance that may also help doctors determine which people with early stage Alzheimer's disease are most likely to experience rapid cognitive decline. The findings of the study are yet to be published in a peer-reviewed TyG Index Test for Alzheimer'sFor this study, researchers analyzed medical records from 315 adults with an average age of about 70 that did not have diabetes. Two hundred of the study participants had received biological confirmation they had Alzheimer's disease. All study participants received insulin resistance assessment using a test called the triglyceride-glucose (TyG) index, with a clinical follow-up three years later. 'The TyG index is a validated marker of insulin resistance, a condition often seen in prediabetes or metabolic syndrome,' Gumina explained. 'It combines triglycerides and fasting blood glucose, two common and non-invasive blood values. (It is) easy to calculate and already available in routine labs.' Higher TyG index results predict quicker cognitive declineAt the study's conclusion, the research team found that when grouping study participants by their TyG index results, those in the highest TyG index group experienced a quicker deterioration in cognitive decline than those with lower TyG index results. 4-fold higher risk'This finding is significant because it highlights a vulnerable window (mild cognitive impairment, the early phase of the disease) when the disease may be especially sensitive to metabolic stress. Patients in this early phase with high TyG levels had a fourfold increased risk of rapid cognitive decline compared to those with lower TyG levels. This suggests that insulin resistance may actively influence how fast Alzheimer's progresses, and identifying this risk early could open new avenues for intervention.'— Bianca Gumina, MD'The TyG index is a low-cost, widely available tool that could be easily integrated into routine clinical practice to flag patients at higher risk of rapid decline,' she continued. 'By identifying these individuals early, clinicians could prioritize them for closer monitoring, lifestyle interventions, or even enrollment in clinical trials, maybe individualizing sub phenotypes of the disease. It also supports the development of metabolic-based treatment strategies, potentially paving the way for therapies targeting insulin resistance to modify disease progression.'As for the next steps in this research, Gumina said the research group is currently exploring whether the TyG index also correlates with neuroimaging biomarkers of brain degeneration. 'The next goal is to integrate metabolic profiling with genetic and imaging data to refine risk models and guide early, personalized interventions,' she added. New potential variable for Alzheimer's progression predictionsMNT spoke with Rehan Aziz, MD, geriatric psychiatrist at Jersey Shore University Medical Center in New Jersey, about this study. Aziz commented that he thought this was a very interesting study involving a new variable to consider when working with patients in the early stages of Alzheimer's dementia, especially as it may predict who is likely to decline faster.'Accurate progression prediction is crucial for multiple reasons,' he explained. 'It empowers families to make informed decisions about care planning, financial arrangements, and how to prioritize quality time together. Clinically, it helps us identify patients who need more intensive monitoring and earlier intervention.''With new disease-modifying treatments like aducanumab and lecanemab becoming available — treatments that carry real risks including brain swelling and bleeding — we urgently need better ways to identify which patients are most likely to benefit from aggressive treatment versus those who might have slower progression,' Aziz continued.'This metabolic marker could help us personalize the risk-benefit calculation for each patient, ensuring we're offering these powerful but potentially risky therapies to those who need them most while protecting slower-progressing patients from unnecessary exposure.'— Rehan Aziz, MDAziz said he'd like to see this study's results validated in larger populations. 'We also need longer follow-up studies to see if this predictive power holds over five to 10 years,' he continued. 'I'm particularly interested in whether interventions targeting insulin resistance — like lifestyle modifications or medications like metformin — could actually slow progression in high-TyG patients. Finally, I'd like to see this integrated with other biomarkers to create a more comprehensive risk stratification tool.' More information on how Alzheimer's progressesMNT also spoke with Peter Gliebus, MD, director of cognitive and behavioral neurology at Marcus Neuroscience Institute, part of Baptist Health South Florida, about this commented that he found the study both fascinating and highly applicable to daily clinical practice. 'As clinicians, we frequently encounter questions from patients and their families, such as, 'How quickly will it worsen?'— and we often don't have a definitive answer,' he explained. 'The prospect that a simple, cost-effective marker like the TyG index could predict progression in Alzheimer's disease is extremely encouraging. It has the potential to bridge an important gap between diagnosis and practical prognosis, which has been a missing element in this field,' he said.'Early-stage Alzheimer's, especially during the mild cognitive impairment stage, exhibits significant variability-some individuals remain stable for years, while others decline rapidly. Identifying those at higher risk of swift decline enables us to customize clinical care and research strategies. It also helps families set clearer expectations and facilitates early, potentially more effective interventions, whether through lifestyle changes, medications or future planning.' — Peter Gliebus, MD'As new treatments are developed, timing and patient stratification will be essential — tools like the TyG index may play a crucial role in that process,' he added.
BBC News
a day ago
- BBC News
'Mum's young-onset dementia is 'heartbreaking' says Bristol woman
The daughter of a 58-year-old woman diagnosed with young-onset dementia is sharing her experience to help raise awareness of the Britton, 29, from Bristol, said she knew the symptoms her mum, Maria Britton, was showing in 2023 seemed serious but after initially being put down to the menopause it took months of "pushing" to discover the true Britton, who works as a cabin manager for EasyJet, said in under two years she had gone from being her mum's daughter to her carer which was "heartbreaking".A spokesperson for the Alzheimer's Society said dementia is the leading cause of death in the UK and one in three people will develop dementia in their lifetime. Dementia is most common in people over the age of 65, but about 70,800 people in the UK are living with young-onset dementia, typically diagnosed before the age of 65, according to the Alzheimer's Britton said she wanted to raise awareness as "so many" people talk about cancer, but few realise the likelihood of developing dementia. Less than two years ago, Ms Britton, her mum, and her brother Harry were looking forward to the "holiday of a lifetime" in Disneyland, Florida."My brother had generously paid for my mum, who had always wanted to go, but just before we went things didn't seem right with her," she said."She'd become withdrawn and quiet and went from being so excited, to seeming like she couldn't care less, and lost her normal mannerisms."I was constantly asking her 'are you okay?'. I knew something was wrong, but I didn't know what." 'Really quiet' After they returned home, Ms Britton said her mum, who worked in accounts, admitted she had been making mistakes at work, but she did not know encouraged her to visit a doctor and Maria was told she was experiencing symptoms of the menopause and put on was between September and December 2023, during which time Maria's boss suggested she take time off work to get better."By January she'd become really quiet and distanced herself, like she didn't really want to talk," said Ms Britton."It was really, really strange and not like her, because she was so chatty before, you could never get her to be quiet."Ms Britton pushed for another GP appointment and her mum was referred for a CT scan but no abnormalities were highlighted so she was referred to a brain clinic. Maria resigned from her job, Ms Britton said, adding: "Her speech deteriorated, she would stutter a lot, and she gradually became unable to put sentences together."She was referred to the Dementia Wellbeing Service who visited within the month."That was around the end of August and they did a really thorough investigation, and by this time, mum's speech was worse along with the motor skills of her hands," Ms Britton said."The dementia clinic came back and said mum has a dementia and they believed it to be the behavioural variant - frontotemporal dementia." Having frontotemporal dementia means her mum still knows who everyone is but it has impacted her speech and personality."Mum can only say yes or no now, and her processing's so bad she can't do anything for herself except walk around. In every aspect of her life she needs help," Ms Britton visit three times a day but Ms Britton prepares all her mum's meals, as well as cleaning, shopping and helping her shower. "I change her bedding. I do her laundry. I take care of her finances. I take her to all her appointments. So anything a human needs, especially someone who does have an illness, I do for her." 'Quite scary' Ms Britton said: "At times it is overwhelming and crazy. Twenty months ago she was working, she seemed herself, and now, I'm like her parent, you know the roles are reversed significantly."Now she loves Peppa Pig and Paw Patrol… she loves walking around with her teddy bear."Some days I think – and it sounds selfish – but I just wish I didn't have to be this carer role anymore, because it takes so much away from me and my mum, too."But I never want to see mum sad, so everything I do is for her."Ms Britton and her brother Harry have learned the dementia her mum has is hereditary, so they her are in the process of being referred to a genetics clinic."We can be tested if we want to be. It's quite scary but we're just trying to get on with everything, maintain our lives and be as happy as we can be." Ms Britton wants to raise awareness of the condition and recently joined more than 1,000 people for a 26-mile (41.8km) fundraising walk in the Lake District with her brother Harry and partner than £600,000 was raised for the Alzheimer's Society, with the charity being fundamental to helping her cope, she said."They supported me and my family through the diagnosis and they're there at the end of the phone whenever you need them", she Britton said people do not realise how quickly dementia can deteriorate and advised anyone else going through something similar to "trust your instinct"."I knew immediately on that holiday there was so much more to the quietness and her being withdrawn. I even Googled early-onset dementia when I was away and everyone thought I was being silly."With something like this, the earlier you can - not catch it, because obviously it's not fixable - but the earlier you can recognise signs the easier it is for things to be put in place quicker."
Daily Mail
2 days ago
- Daily Mail
How plaque and gum disease can lead to dementia: As doctors unveil startling research, experts reveal ultimate guide to the brushes, floss and toothpaste that really work to keep you healthy
If eyes are the window to the soul, then the mouth is a portal to the mind, according to the British Dental Association. 'There's emerging evidence that poor oral health – plaque formation, gum disease and tooth loss – is a risk factor for dementia, including Alzheimer's disease,' says Eddie Crouch, the association's chair. A slew of recent research suggests that what happens in your mouth can have wider health implications. Several large studies have discovered links between periodontitis (that's chronic gum disease to you and me) and an increased risk of cognitive decline.
